Continuing the tradition of the previous nine meetings, the goals of CPP 2026 are to advance the knowledge and expertise of healthcare professionals worldwide in managing cardiovascular (CV) diseases during pregnancy. This will be achieved through the exchange of information and updates on recent data.
The meeting will include numerous plenary sessions featuring state-of-the-art reviews by renowned experts. It will incorporate the results of contemporary research as well as clinical observations and case presentations, followed by expert discussions.
As the management of heart disease in pregnancy requires a multidisciplinary approach, the intended audience includes cardiologists, obstetricians, maternal-fetal medicine specialists, obstetrical and cardiac anesthesiologists, family medicine specialists, hematologists, pediatricians, pediatric cardiologists, geneticists, cardiac surgeons, neonatologists, nurses, clinical pharmacists, and other healthcare professionals with a special interest in managing pregnant women with heart disease.